Ignite Creation Date:
2024-05-06 @ 9:23 AM
Last Modification Date:
2024-10-26 @ 12:13 PM
Study NCT ID:
NCT02960620
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2022-09-28
First Post:
2016-11-08
Brief Title:
Therasphere for Unresectable Primary or Secondary Liver Neoplasia
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Study Overview
Official Title:
A Humanitarian Device Exemption HDE Treatment Protocol of TheraSphere For Treatment of Unresectable Primary or Secondary Liver Neoplasia - HDE 980006
Status:
NO_LONGER_AVAILABLE
Status Verified Date:
2022-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is not a research study The purpose is to provide supervised access to TheraSphere therapy at this institution
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None